Funds eye strategies on iTraxx, CDX roll

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Funds eye strategies on iTraxx, CDX roll

MichaelHunseler

Hedge funds and asset managers are looking at various strategies on the iTraxx and CDX indices in an effort to profit ahead of the roll to series 21 on March 20. Michael Hünseler, who manages Assenagon’s €200m credit selection fund in Munich, told GlobalCapital that the fund was looking at selling protection on the new names that will be included in the iTraxx Crossover ahead of the roll.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request demo or Login
  • 4,000 annual insights
  • 700+ notes and long-form analyses
  • 4 capital markets databases
  • Daily newsletters across markets and asset classes
  • 2 weekly podcasts

Related articles

Gift this article